Xanthogranuloma, Juvenile
"Xanthogranuloma, Juvenile" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benign disorder of infants and children caused by proliferation of HISTIOCYTES, macrophages found in tissues. These histiocytes, usually lipid-laden non-Langerhans cells, form multiple yellow-red nodules most often in the skin, the eye, and sometimes in the viscera. Patients appear to have normal lipid metabolism and are classified as a normolipemic non-Langerhans cell histiocytosis.
| Descriptor ID |
D014972
|
| MeSH Number(s) |
C15.604.250.410.900 C17.800.973
|
| Concept/Terms |
Xanthogranuloma, Juvenile- Xanthogranuloma, Juvenile
- Juvenile Xanthogranuloma
- Juvenile Xanthogranulomas
- Xanthogranulomas, Juvenile
- Xanthoma, Juvenile
- Juvenile Xanthoma
- Juvenile Xanthomas
- Xanthomas, Juvenile
- Nevoxanthoendothelioma
- Nevoxanthoendotheliomas
|
Below are MeSH descriptors whose meaning is more general than "Xanthogranuloma, Juvenile".
Below are MeSH descriptors whose meaning is more specific than "Xanthogranuloma, Juvenile".
This graph shows the total number of publications written about "Xanthogranuloma, Juvenile" by people in this website by year, and whether "Xanthogranuloma, Juvenile" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Xanthogranuloma, Juvenile" by people in Profiles.
-
Neuroimaging in Pediatric Patients with Juvenile Xanthogranuloma of the CNS. AJNR Am J Neuroradiol. 2022 11; 43(11):1667-1673.
-
Histiocytic Disorders of Childhood. Pediatr Rev. 2022 Oct 01; 43(10):561-571.
-
Histiocytic Diseases of Neonates: Langerhans Cell Histiocytosis, Rosai-Dorfman Disease, and Juvenile Xanthogranuloma. Clin Perinatol. 2021 03; 48(1):167-179.
-
Juvenile xanthogranuloma: A herald to the diagnosis of Erdheim-Chester disease in an adult with acute leukemia. J Cutan Pathol. 2018 Dec; 45(12):914-917.
-
Firm, hyperpigmented subcutaneous nodule in the inguinal fold of an infant. Dermatol Online J. 2018 May 15; 24(5).
-
Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma. Oncotarget. 2017 Jul 11; 8(28):46065-46070.
-
Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders. Hematology Am Soc Hematol Educ Program. 2015; 2015:559-64.
-
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 2014 Nov 06; 124(19):3007-15.
-
Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease. Pediatr Blood Cancer. 2014 Mar; 61(3):479-87.
-
Disseminated intracranial juvenile xanthogranulomatosis in a neonate without cutaneous lesions. J Neurosurg Pediatr. 2013 Aug; 12(2):187-91.